Al Saidi Ahmed, Al Shamsi Mohammed, Al Farsi Abdulmunaim, Al Tubi Saif
Emergency Medicine, Sohar Hospital, Sohar, OMN.
Emergency Medicine, Armed Forces Hospital, Muscat, OMN.
Cureus. 2025 Mar 10;17(3):e80375. doi: 10.7759/cureus.80375. eCollection 2025 Mar.
This study aimed to observe changes in serum glucose levels following the administration of 50 mL of 50% dextrose solution (D50) in hypoglycemic patients. Specifically, we seek to determine the prevalence of rebound hyperglycemia episodes, the peak effect, and the duration of action of a single dose of 50 mL D50.
This prospective observational study was conducted at four emergency departments (two tertiary care hospitals and two secondary care hospitals) in Oman over a three-year period, from May 1, 2019, to April 30, 2022. Adult patients (>12 years old) presenting with documented hypoglycemia (serum glucose level ≤3.9 mmol/L) were included. All patients underwent bedside serum glucose measurements at predetermined time intervals following the administration of D50. Data were analyzed using the Epidata program (Buenos Aires, Argentina). The mean serum glucose level at each time interval was calculated, along with the prevalence of rebound hyperglycemia. The independent sample t-test, one-way ANOVA, and Pearson's chi-squared test were used for statistical analysis.
A total of 102 patients (53 females and 48 males) were included in this study. The majority of patients were diabetic (N = 87), while 15 (14.7%) were non-diabetic. Rebound hyperglycemia was predominantly observed within five minutes of administering 50 mL of D50, with a mean serum glucose level of 12.2 mmol/L and a maximum reading of 22.6 mmol/L. Rebound hyperglycemia occurred more frequently in the non-diabetic group (73.3%) compared to the diabetic group (56.3%). Six patients (5.7%) required a second dose of 50 mL D50, all of whom were diabetic.
A single dose of 50 mL D50 effectively restores and maintains the desired serum glucose level in non-diabetic hypoglycemic adult patients for up to 60 minutes. However, diabetic patients may require additional doses or continuous dextrose-containing fluids if they do not begin oral feeding. Using a lower concentration of dextrose-containing fluids may help mitigate the phenomenon of rebound hyperglycemia.
本研究旨在观察低血糖患者静脉注射50 mL 50%葡萄糖溶液(D50)后血糖水平的变化。具体而言,我们试图确定反弹性高血糖发作的发生率、单剂量50 mL D50的峰值效应和作用持续时间。
本前瞻性观察性研究于2019年5月1日至2022年4月30日在阿曼的四个急诊科(两家三级护理医院和两家二级护理医院)进行,为期三年。纳入有记录的低血糖(血清葡萄糖水平≤3.9 mmol/L)的成年患者(>12岁)。所有患者在注射D50后的预定时间间隔进行床边血糖测量。使用Epidata程序(阿根廷布宜诺斯艾利斯)分析数据。计算每个时间间隔的平均血清葡萄糖水平以及反弹性高血糖的发生率。采用独立样本t检验、单因素方差分析和Pearson卡方检验进行统计分析。
本研究共纳入102例患者(53例女性和48例男性)。大多数患者为糖尿病患者(N = 87),而15例(14.7%)为非糖尿病患者。反弹性高血糖主要在注射50 mL D50后5分钟内出现,平均血清葡萄糖水平为12.2 mmol/L,最高读数为22.6 mmol/L。与糖尿病组(56.3%)相比,非糖尿病组反弹性高血糖的发生率更高(73.3%)。6例患者(5.7%)需要第二次注射50 mL D50,所有这些患者均为糖尿病患者。
单剂量50 mL D50可有效恢复并维持非糖尿病低血糖成年患者的目标血糖水平长达60分钟。然而,如果糖尿病患者未开始经口进食,可能需要额外剂量或持续输注含葡萄糖液体。使用较低浓度的含葡萄糖液体可能有助于减轻反弹性高血糖现象。